Goldman Sachs’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.07M | Buy |
|
|||||
|
2025
Q1 | $3.37M | Buy |
|
|||||
|
2024
Q4 | $4.09M | Sell |
|
|||||
|
2024
Q3 | $9.92M | Sell |
|
|||||
|
2024
Q2 | $56.9M | Buy |
|
|||||
|
2024
Q1 | $52.7M | Sell |
|
|||||
|
2023
Q4 | $20.8M | Buy |
|
|||||
|
2023
Q3 | $6.58M | Sell |
|
|||||
|
2023
Q2 | $11.2M | Buy |
|
|||||
|
2023
Q1 | $11.2M | Buy |
|
|||||
|
2022
Q4 | $749K | Buy |
|
|||||
|
2022
Q3 | $101K | Sell |
|
|||||
|
2022
Q2 | $166K | Sell |
|
|||||
|
2022
Q1 | $781K | Buy |
|
|||||
|
2021
Q4 | $400K | Sell |
|
|||||
|
2021
Q3 | $883K | Sell |
|
|||||
|
2021
Q2 | $1.75M | Buy |
|
|||||
|
2021
Q1 | $310K | Sell |
|
|||||
|
2020
Q4 | $438K | Sell |
|
|||||
|
2020
Q3 | $3.64M | Buy |
|
|||||
|
2020
Q2 | $4.15M | Buy |
|
|||||
|
2020
Q1 | $389K | Sell |
|
|||||
|
2019
Q4 | $1.15M | Buy |
|
|||||
|
2019
Q3 | $657K | Buy |
|
|||||
|
2019
Q2 | $243K | Sell |
|
|||||
|
2019
Q1 | $648K | Sell |
|
|||||
|
2018
Q4 | $1.69M | Buy |
|
|||||
|
2018
Q3 | $1.82M | Sell |
|
|||||
|
2018
Q2 | $1.09M | Sell |
|
|||||
|
2018
Q1 | $924K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $35K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $44K | Sell |
|
|||||
|
2015
Q3 | $107K | Sell |
|
|||||
|
2015
Q2 | $169K | Buy |
|